TrialPanorama/Dataset huggingface dataset:
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Double-blind, Placebo- and Active-controlled, Fixed-dose Study of Vilazodone in Patients With Major Depressive Disorder
Brief Summary: The purpose of this study was to evaluate the efficacy, safety, and tolerability of 2 fixed dose levels of vilazodone compared to placebo in patients with major depressive disorder.


Options:
A: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Drug: Aripiprazole (Fixed dose) | Arm Label: 2; Type: EXPERIMENTAL; Interventions: Drug: Aripiprazole (Titrated dose) | Arm Label: 3; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: Aripiprazole (Fixed dose); Assigned to Arm(s): 1 | Intervention Type: DRUG; Name: Aripiprazole (Titrated dose); Assigned to Arm(s): 2 | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): 3
B: Arm Label: Duloxetine Hydrochloride (60 mg); Type: EXPERIMENTAL; Interventions: Drug: Duloxetine hydrochloride, Drug: Placebo | Arm Label: Duloxetine Hydrochloride (120 mg); Type: EXPERIMENTAL; Interventions: Drug: Duloxetine hydrochloride, Drug: Placebo | Intervention Type: DRUG; Name: Duloxetine hydrochloride; Assigned to Arm(s): Duloxetine Hydrochloride (120 mg), Duloxetine Hydrochloride (60 mg) | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Duloxetine Hydrochloride (120 mg), Duloxetine Hydrochloride (60 mg)
C: Arm Label: Lithium; Type: ACTIVE_COMPARATOR; Interventions: Drug: Lithium | Arm Label: Quetiapine; Type: EXPERIMENTAL; Interventions: Drug: Quetiapine | Intervention Type: DRUG; Name: Quetiapine; Assigned to Arm(s): Quetiapine | Intervention Type: DRUG; Name: Lithium; Assigned to Arm(s): Lithium
D: Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo to citalopram, Drug: Placebo to vilazodone | Arm Label: Vilazodone 20 mg/day; Type: EXPERIMENTAL; Interventions: Drug: Vilazodone, Drug: Placebo to citalopram, Drug: Placebo to vilazodone | Arm Label: Vilazodone 40 mg/day; Type: EXPERIMENTAL; Interventions: Drug: Vilazodone, Drug: Placebo to citalopram, Drug: Placebo to vilazodone | Arm Label: Citalopram 40 mg/day; Type: ACTIVE_COMPARATOR; Interventions: Drug: Placebo to vilazodone, Drug: Citalopram | Intervention Type: DRUG; Name: Vilazodone; Assigned to Arm(s): Vilazodone 20 mg/day, Vilazodone 40 mg/day | Intervention Type: DRUG; Name: Placebo to citalopram; Assigned to Arm(s): Placebo, Vilazodone 20 mg/day, Vilazodone 40 mg/day | Intervention Type: DRUG; Name: Placebo to vilazodone; Assigned to Arm(s): Citalopram 40 mg/day, Placebo, Vilazodone 20 mg/day, Vilazodone 40 mg/day | Intervention Type: DRUG; Name: Citalopram; Assigned to Arm(s): Citalopram 40 mg/day

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Avoiding Diabetes Thru Action Plan Targeting (ADAPT): A Pilot Randomized Control Trial of an Electronic Medical Record Embedded Prediabetes Shared Goal Setting Tool in Primary Care
Brief Summary: The goal of this randomized control trial is to study the impact of an electronic health record embedded tool's ability to facilitate shared provider-patient goal setting to promote lifestyle behavior change and prevent diabetes in primary care.


Options:
A: Intervention Type: DEVICE; Name: Decision Aid Statin Choice; Assigned to Arm(s): N/A
B: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Other: PT Tool - interactive, computerized, prenatal testing decision tool | Arm Label: 2; Type: ACTIVE_COMPARATOR; Interventions: Other: Control - computerized age-appropriate prenatal testing educational brochure | Intervention Type: OTHER; Name: Control - computerized age-appropriate prenatal testing educational brochure; Assigned to Arm(s): 2 | Intervention Type: OTHER; Name: PT Tool - interactive, computerized, prenatal testing decision tool; Assigned to Arm(s): 1
C: Arm Label: White educational video; Type: N/A; Interventions: N/A | Arm Label: African-American educational video; Type: N/A; Interventions: N/A | Arm Label: Usual care; Type: N/A; Interventions: N/A
D: Arm Label: ADAPT tool; Type: EXPERIMENTAL; Interventions: Behavioral: ADAPT tool | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: ADAPT tool; Assigned to Arm(s): ADAPT tool

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Caring Letters for Military Suicide Prevention: A Randomized Controlled Trial
Brief Summary: The purpose of this multi-site randomized controlled trial is to determine if the Caring Letters intervention is effective in preventing suicide and suicidal behaviors among U.S. Service Members and Veterans. The primary aim of this project is determine whether caring communications following inpatient psychiatric treatment reduce suicide and self-inflicted injuries among U.S. military personnel and Veterans. The investigators will also explore treatment utilization by comparing the frequency of treatment visits after enrollment into the study. The following specific hypotheses will be tested:

Hypothesis 1: During a two year follow-up after the index hospital discharge, the frequency of suicide will be lower among participants in the Caring Letters group compared to those in the Usual Care group.

Hypothesis 2: The frequency of medically admitted self-inflicted injuries will also be lower in the Caring Letters group compared to the Usual Care group.

Hypothesis 3: The time to suicidal act, among those who do subsequently exhibit one, will be longer among participants in the Caring Letters group compared to the Usual Care group.


Options:
A: Arm Label: Caring Letter Condition (CL); Type: EXPERIMENTAL; Interventions: Behavioral: Caring Letter (email) | Arm Label: Usual Care (UC); Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Caring Letter (email); Assigned to Arm(s): Caring Letter Condition (CL)
B: Arm Label: Brief Admission; Type: EXPERIMENTAL; Interventions: Other: Brief Admission | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: Brief Admission; Assigned to Arm(s): Brief Admission
C: Arm Label: Immediate Functional Imagery Training (FIT); Type: EXPERIMENTAL; Interventions: Behavioral: Functional Imagery Training (FIT) | Arm Label: Delayed Functional Imagery Training (FIT); Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Functional Imagery Training (FIT); Assigned to Arm(s): Immediate Functional Imagery Training (FIT)
D: Arm Label: Psychosocial group intervention; Type: EXPERIMENTAL; Interventions: Behavioral: 10 weekly group meetings, Behavioral: Outpatient counseling and support groups | Arm Label: Control; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Outpatient counseling and support groups | Intervention Type: BEHAVIORAL; Name: 10 weekly group meetings; Assigned to Arm(s): Psychosocial group intervention | Intervention Type: BEHAVIORAL; Name: Outpatient counseling and support groups; Assigned to Arm(s): Control, Psychosocial group intervention

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Caring Letters for Military Suicide Prevention: A Randomized Controlled Trial
Brief Summary: The purpose of this multi-site randomized controlled trial is to determine if the Caring Letters intervention is effective in preventing suicide and suicidal behaviors among U.S. Service Members and Veterans. The primary aim of this project is determine whether caring communications following inpatient psychiatric treatment reduce suicide and self-inflicted injuries among U.S. military personnel and Veterans. The investigators will also explore treatment utilization by comparing the frequency of treatment visits after enrollment into the study. The following specific hypotheses will be tested:

Hypothesis 1: During a two year follow-up after the index hospital discharge, the frequency of suicide will be lower among participants in the Caring Letters group compared to those in the Usual Care group.

Hypothesis 2: The frequency of medically admitted self-inflicted injuries will also be lower in the Caring Letters group compared to the Usual Care group.

Hypothesis 3: The time to suicidal act, among those who do subsequently exhibit one, will be longer among participants in the Caring Letters group compared to the Usual Care group.


Options:
A: Arm Label: Brief Intervention; Type: EXPERIMENTAL; Interventions: Behavioral: Brief Intervention for Suicidality | Arm Label: care as usual; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Brief Intervention for Suicidality; Assigned to Arm(s): Brief Intervention
B: Arm Label: Caring Letter Condition (CL); Type: EXPERIMENTAL; Interventions: Behavioral: Caring Letter (email) | Arm Label: Usual Care (UC); Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Caring Letter (email); Assigned to Arm(s): Caring Letter Condition (CL)
C: Arm Label: MBT therapy plus treatment as usual; Type: EXPERIMENTAL; Interventions: Other: Mentalization-Based Group Therapy for Adolescents | Arm Label: Treatment as usual alone; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: Mentalization-Based Group Therapy for Adolescents; Assigned to Arm(s): MBT therapy plus treatment as usual
D: Arm Label: Positive Psychology; Type: EXPERIMENTAL; Interventions: Behavioral: Positive Psychology | Arm Label: Organizational Skills; Type: SHAM_COMPARATOR; Interventions: Behavioral: Control Condition | Intervention Type: BEHAVIORAL; Name: Positive Psychology; Assigned to Arm(s): Positive Psychology | Intervention Type: BEHAVIORAL; Name: Control Condition; Assigned to Arm(s): Organizational Skills

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Online Early Resilience Intervention for Combat-Related PTSD in Military Primary Healthcare Settings: A Randomized Trial of "DESTRESS-PC"
Brief Summary: This study will compare a cognitive-behavioral online self-management intervention designed for primary care treatment of war-related PTSD to a control intervention, "optimized usual primary care PTSD treatment". Patients with PTSD will be trained to use the online PTSD treatment website and asked to do so three times per week for six weeks. They will have phone and email access to a nurse trained to assist them in their treatment program. Three scheduled phone check-ins during the six week treatment period will provide ongoing contact with patients during treatment. The investigators will assess PTSD symptoms, depression, anxiety and somatic symptoms, physical health status and occupational functioning on three occasions: before the intervention, at the end of the treatment period, and six weeks after the end of treatment.


Options:
A: Arm Label: Cognitive behavioral program; Type: EXPERIMENTAL; Interventions: Behavioral: an in-home cognitive behavioral program | Arm Label: Control group; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: an in-home cognitive behavioral program; Assigned to Arm(s): Cognitive behavioral program
B: Arm Label: Education about falls; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Fall prevention education | Arm Label: Activity, Balance, Learning, and Exposure; Type: EXPERIMENTAL; Interventions: Behavioral: Activity, Balance, Learning, and Exposure | Intervention Type: BEHAVIORAL; Name: Activity, Balance, Learning, and Exposure; Assigned to Arm(s): Activity, Balance, Learning, and Exposure | Intervention Type: BEHAVIORAL; Name: Fall prevention education; Assigned to Arm(s): Education about falls
C: Arm Label: DESTRESS-PC; Type: EXPERIMENTAL; Interventions: Behavioral: DESTRESS-PC | Arm Label: OUC; Type: ACTIVE_COMPARATOR; Interventions: Other: Optimized Usual Primary Care PTSD treatment | Intervention Type: BEHAVIORAL; Name: DESTRESS-PC; Assigned to Arm(s): DESTRESS-PC | Intervention Type: OTHER; Name: Optimized Usual Primary Care PTSD treatment; Assigned to Arm(s): OUC
D: Arm Label: DESTRESS-WV; Type: EXPERIMENTAL; Interventions: Behavioral: DESTRESS-WV | Arm Label: Phone Monitoring; Type: PLACEBO_COMPARATOR; Interventions: Behavioral: Phone Monitoring | Intervention Type: BEHAVIORAL; Name: DESTRESS-WV; Assigned to Arm(s): DESTRESS-WV | Intervention Type: BEHAVIORAL; Name: Phone Monitoring; Assigned to Arm(s): Phone Monitoring

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Effectiveness of Implementation Strategy for a Breastfeeding Guideline in Primary Care: Cluster Randomised Trial
Brief Summary: The purpose of this study is to determine whether an implementation strategy for a breastfeeding guide is more effective than the usual practice (simple circulation of the guide) in terms of increasing the percentage of children receiving exclusive or preferential breastfeeding at 6 months age.


Options:
A: Intervention Type: BEHAVIORAL; Name: Home Nurse Visit; Assigned to Arm(s): N/A
B: Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Low Intensity; Type: OTHER; Interventions: Other: Telephone-based breastfeeding peer counseling | Arm Label: High Intensity; Type: ACTIVE_COMPARATOR; Interventions: Other: Telephone-based breastfeeding peer counseling | Intervention Type: OTHER; Name: Telephone-based breastfeeding peer counseling; Assigned to Arm(s): High Intensity, Low Intensity
C: Arm Label: Home-based counselling visits by volunteers; Type: EXPERIMENTAL; Interventions: Behavioral: Home-based counselling | Arm Label: Standard care through existing health system; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Home-based counselling; Assigned to Arm(s): Home-based counselling visits by volunteers
D: Arm Label: implementation strategy; Type: EXPERIMENTAL; Interventions: Other: implementation strategy of Breastfeeding | Arm Label: Conventional intervention; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: implementation strategy of Breastfeeding; Assigned to Arm(s): implementation strategy

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Effectiveness of Implementation Strategy for a Breastfeeding Guideline in Primary Care: Cluster Randomised Trial
Brief Summary: The purpose of this study is to determine whether an implementation strategy for a breastfeeding guide is more effective than the usual practice (simple circulation of the guide) in terms of increasing the percentage of children receiving exclusive or preferential breastfeeding at 6 months age.


Options:
A: Arm Label: Breastfeeding Peer Counseling; Type: EXPERIMENTAL; Interventions: Behavioral: Breastfeeding Peer Counseling | Arm Label: Standard Care; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Breastfeeding Peer Counseling; Assigned to Arm(s): Breastfeeding Peer Counseling
B: Arm Label: MILK intervention group; Type: EXPERIMENTAL; Interventions: Behavioral: MILK or Text4Baby text message intervention | Arm Label: Text4Baby control intervention group; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: MILK or Text4Baby text message intervention | Intervention Type: BEHAVIORAL; Name: MILK or Text4Baby text message intervention; Assigned to Arm(s): MILK intervention group, Text4Baby control intervention group
C: Arm Label: Lactation Consultant; Type: ACTIVE_COMPARATOR; Interventions: Other: Lactation Consultant support | Arm Label: current treatment for jaundice; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: Lactation Consultant support; Assigned to Arm(s): Lactation Consultant
D: Arm Label: implementation strategy; Type: EXPERIMENTAL; Interventions: Other: implementation strategy of Breastfeeding | Arm Label: Conventional intervention; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: implementation strategy of Breastfeeding; Assigned to Arm(s): implementation strategy

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Effectiveness of Implementation Strategy for a Breastfeeding Guideline in Primary Care: Cluster Randomised Trial
Brief Summary: The purpose of this study is to determine whether an implementation strategy for a breastfeeding guide is more effective than the usual practice (simple circulation of the guide) in terms of increasing the percentage of children receiving exclusive or preferential breastfeeding at 6 months age.


Options:
A: Arm Label: BFHI steps 1-9; Type: EXPERIMENTAL; Interventions: Other: implementation of the Baby-Friendly Hospital Initiative | Arm Label: BFHI steps 1-9 +well-child clinic; Type: EXPERIMENTAL; Interventions: Other: BFHI steps 1-9 +well-child clinic | Arm Label: usual care; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: implementation of the Baby-Friendly Hospital Initiative; Assigned to Arm(s): BFHI steps 1-9 | Intervention Type: OTHER; Name: BFHI steps 1-9 +well-child clinic; Assigned to Arm(s): BFHI steps 1-9 +well-child clinic
B: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Behavioral: Infant Sleeping and Soothing | Arm Label: 2; Type: EXPERIMENTAL; Interventions: Behavioral: Repeated Food Exposure | Arm Label: 3; Type: EXPERIMENTAL; Interventions: Behavioral: Infant Sleeping and Soothing, Behavioral: Repeated Food Exposure | Arm Label: 4; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Infant Sleeping and Soothing; Assigned to Arm(s): 1, 3 | Intervention Type: BEHAVIORAL; Name: Repeated Food Exposure; Assigned to Arm(s): 2, 3
C: Arm Label: implementation strategy; Type: EXPERIMENTAL; Interventions: Other: implementation strategy of Breastfeeding | Arm Label: Conventional intervention; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: implementation strategy of Breastfeeding; Assigned to Arm(s): implementation strategy
D: Arm Label: Home-based counselling visits by volunteers; Type: EXPERIMENTAL; Interventions: Behavioral: Home-based counselling | Arm Label: Standard care through existing health system; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Home-based counselling; Assigned to Arm(s): Home-based counselling visits by volunteers

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Randomized Non Comparative Phase II Trial With Bevacizumab and Fotemustine in the Treatment of Recurrent Glioblastoma
Brief Summary: This randomized, non-comparative study will evaluate the efficacy and safety of Avastin (bevacizumab) in patients with recurrent glioblastoma. Patients will be randomized to receive Avastin 10 mg/kg intravenously every 2 weeks or fotemustine 75 mg/m2 on days 1, 8 and 15, followed by, after a 5 weeks interval, 100 mg/m2 intravenously every 3 weeks. Treatment with fotemustine serves as a calibration arm and no formal efficacy comparison will be made between the two treatment arms. The anticipated time of study treatment is until disease progression or unacceptable toxicity.


Options:
A: Arm Label: ADV-TK/GCV; Type: EXPERIMENTAL; Interventions: Biological: ADV-TK/GCV | Arm Label: Control group; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Surgery, Drug: systemic chemotherapy | Intervention Type: BIOLOGICAL; Name: ADV-TK/GCV; Assigned to Arm(s): ADV-TK/GCV | Intervention Type: PROCEDURE; Name: Surgery; Assigned to Arm(s): Control group | Intervention Type: DRUG; Name: systemic chemotherapy; Assigned to Arm(s): Control group
B: Arm Label: ABT-414/temozolomide; Type: EXPERIMENTAL; Interventions: Drug: Depatuxizumab mafodotin, Drug: Temozolomide | Arm Label: ABT-414_adult; Type: EXPERIMENTAL; Interventions: Drug: Depatuxizumab mafodotin | Arm Label: Control_lomustine; Type: ACTIVE_COMPARATOR; Interventions: Drug: Lomustine | Arm Label: Control_ temozolomide; Type: ACTIVE_COMPARATOR; Interventions: Drug: Temozolomide | Arm Label: ABT-414_ pediatric; Type: EXPERIMENTAL; Interventions: Drug: Depatuxizumab mafodotin | Intervention Type: DRUG; Name: Depatuxizumab mafodotin; Assigned to Arm(s): ABT-414/temozolomide, ABT-414_ pediatric, ABT-414_adult | Intervention Type: DRUG; Name: Temozolomide; Assigned to Arm(s): ABT-414/temozolomide, Control_ temozolomide | Intervention Type: DRUG; Name: Lomustine; Assigned to Arm(s): Control_lomustine
C: Arm Label: Calibration Arm; Type: EXPERIMENTAL; Interventions: Drug: fotemustine | Arm Label: Investigational Arm; Type: EXPERIMENTAL; Interventions: Drug: bevacizumab [Avastin] | Intervention Type: DRUG; Name: bevacizumab [Avastin]; Assigned to Arm(s): Investigational Arm | Intervention Type: DRUG; Name: fotemustine; Assigned to Arm(s): Calibration Arm
D: Arm Label: Arm A: SRT to the resection cavity; Type: EXPERIMENTAL; Interventions: Radiation: SRT to the resection cavity | Arm Label: Arm B: Observation; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: RADIATION; Name: SRT to the resection cavity; Assigned to Arm(s): Arm A: SRT to the resection cavity

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Randomized Non Comparative Phase II Trial With Bevacizumab and Fotemustine in the Treatment of Recurrent Glioblastoma
Brief Summary: This randomized, non-comparative study will evaluate the efficacy and safety of Avastin (bevacizumab) in patients with recurrent glioblastoma. Patients will be randomized to receive Avastin 10 mg/kg intravenously every 2 weeks or fotemustine 75 mg/m2 on days 1, 8 and 15, followed by, after a 5 weeks interval, 100 mg/m2 intravenously every 3 weeks. Treatment with fotemustine serves as a calibration arm and no formal efficacy comparison will be made between the two treatment arms. The anticipated time of study treatment is until disease progression or unacceptable toxicity.


Options:
A: Arm Label: Calibration Arm; Type: EXPERIMENTAL; Interventions: Drug: fotemustine | Arm Label: Investigational Arm; Type: EXPERIMENTAL; Interventions: Drug: bevacizumab [Avastin] | Intervention Type: DRUG; Name: bevacizumab [Avastin]; Assigned to Arm(s): Investigational Arm | Intervention Type: DRUG; Name: fotemustine; Assigned to Arm(s): Calibration Arm
B: Arm Label: Temozolomide and Bevacizumab; Type: EXPERIMENTAL; Interventions: Drug: Temozolomide, Drug: Bevacizumab | Intervention Type: DRUG; Name: Temozolomide; Assigned to Arm(s): Temozolomide and Bevacizumab | Intervention Type: DRUG; Name: Bevacizumab; Assigned to Arm(s): Temozolomide and Bevacizumab
C: Arm Label: Bevacizumab + RT + Temozolomide; Type: EXPERIMENTAL; Interventions: Drug: Bevacizumab, Drug: Temozolomide, Radiation: Radiation therapy | Arm Label: Placebo + RT + Temozolomide; Type: PLACEBO_COMPARATOR; Interventions: Drug: Temozolomide, Radiation: Radiation therapy, Drug: Placebo | Intervention Type: DRUG; Name: Bevacizumab; Assigned to Arm(s): Bevacizumab + RT + Temozolomide | Intervention Type: DRUG; Name: Temozolomide; Assigned to Arm(s): Bevacizumab + RT + Temozolomide, Placebo + RT + Temozolomide | Intervention Type: RADIATION; Name: Radiation therapy; Assigned to Arm(s): Bevacizumab + RT + Temozolomide, Placebo + RT + Temozolomide | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo + RT + Temozolomide
D: Arm Label: 5-aminolevulinic acid; Type: EXPERIMENTAL; Interventions: Drug: 5-aminolevulinic acid (5-ALA) | Arm Label: Conventional resection; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: DRUG; Name: 5-aminolevulinic acid (5-ALA); Assigned to Arm(s): 5-aminolevulinic acid

Answer: A